Resultats de la cerca - Fabienne Dominjon
- Mostrar 1 - 2 resultats de 2
-
1
Effect of ivabradine in patients with heart failure with preserved ejection fraction: the <scp>EDIFY</scp> randomized placebo‐controlled trial per Michel Komajda, Richard Isnard, Alain Cohen‐Solal, Marco Metra, Burkert Pieske, Piotr Ponikowski, Adriaan A. Voors, Fabienne Dominjon, Cécile Henon‐Goburdhun, Matthieu Pannaux, Michael Böhm
Publicat 2017Artigo -
2
Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency per Stefan D. Anker, Stefan Schroeder, Dan Atar, Jeroen J. Bax, Claudio Ceconi, Martín Cowie, Adam Crisp, Fabienne Dominjon, Ian Ford, Hossein Ardeschir Ghofrani, Savion Gropper, Gerhard Hindricks, Mark A. Hlatky, Richard Holcomb, Narimon Honarpour, J. Wouter Jukema, Albert M. Kim, Michael Kunz, Martin Lefkowitz, Chantal Le Floch, Ulf Landmesser, Theresa A. McDonagh, John J.V. McMurray, Béla Merkely, Milton Packer, Krishna Prasad, James H. Revkin, Giuseppe Rosano, Ransi Somaratne, Wendy Gattis Stough, Adriaan A. Voors, Frank Ruschitzka
Publicat 2016Revisão
Eines de cerca:
Matèries relacionades
Heart failure
Internal medicine
Medicine
Randomized controlled trial
Adverse effect
Alternative medicine
Atrial fibrillation
Blood pressure
Cardiology
Clinical endpoint
Clinical trial
Ejection fraction
Heart rate
Intensive care medicine
Interquartile range
Ivabradine
Pathology
Physical therapy
Placebo
Sinus rhythm